For much of the current century Australia has conducted an immigration experiment almost unique among developed nations – but ...
Bristol Myers Squibb today announced that the European Commission has granted approval to Sotyktu (deucravacitinib), alone or in combination with methotrexate, for the treatment of active psoriatic ...